1. 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine. (31st December 2020) Authors: Brar, Indira; Ruane, Peter; Ward, Douglas; Molina, Jean-michel; Mills, Anthony; Berhe, Mezgebe; Brinson, Cynthia; Rampogal, Moti; Benson, Paul; Henry, Keith; Huang, Hailin; Andreatta, Kristen; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1251. 5-year outcomes of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 count in two Phase 3 randomized clinical trials. (15th December 2022) Authors: Ramgopal, Moti; Wurapa, Anson; Baumgarten, Axel; Berhe, Mezgebe; Pozniak, Anton; Orkin, Chloe; Tiraboschi, Juan Manuel; Hagins, Debbie P; Huang, Hailin; Andreatta, Kristin; Unger, Nathan; Hindman, Jason; Martin, Hal; Baeten, Jared; Osiyemi, Olayemi Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2143. Incidence of Infection in Patients Receiving Short vs. Long Duration of Antimicrobial Prophylaxis in Neurosurgery. (26th November 2018) Authors: Bast, Chelsea; Colley, Peter; Roth, Jennifer; Nguyen, Hoa; Naftalis, Richard; Berhe, Mezgebe Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems. (26th November 2018) Authors: John, Reeba; Colley, Peter; Nguyen, Hoa; Berhe, Mezgebe Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 75. High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500, 000 c/mL: 48-Week Subgroup Analysis of the STAT Study. (4th December 2021) Authors: Rolle, Charlotte-Paige M; Berhe, Mezgebe; Singh, Tulika; Ortiz, Roberto; Wurapa, Anson K; Ramgopal, Moti; Jayaweera, Dushyantha; Leone, Peter; Matthews, Jessica; Cupo, Michael; Underwood, Mark; Angelis, Kostas; Wynne, Brian; Merrill, Deanna; Nguyen, Christopher T; van Wyk, Jean A; Zolopa, Andrew Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 902. Selection of Antibiotics for Prophylaxis of Left Ventricular Assist Device Surgical Infections: More is Not More. (31st December 2020) Authors: Nguyen, Peter T; Sam, Teena; Colley, Peter; Van Zyl, Johanna; Berhe, Mezgebe; Meyer, Dan Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Issue 9 (September 2022) Authors: Wolfe, Cameron R; Tomashek, Kay M; Patterson, Thomas F; Gomez, Carlos A; Marconi, Vincent C; Jain, Mamta K; Yang, Otto O; Paules, Catharine I; Palacios, Guillermo M Ruiz; Grossberg, Robert; Harkins, Michelle S; Mularski, Richard A; Erdmann, Nathaniel; Sandkovsky, Uriel; Almasri, Eyad; Pineda, Jus... Journal: Lancet Issue: Volume 10:Issue 9(2022) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Brucella, a bacterium with multiple ways of causing infection. Issue 1 (2nd January 2021) Authors: Perez, Alejandro; Berhe, Mezgebe Journal: Proceedings Issue: Volume 34:Issue 1(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV. (1st October 2021) Authors: Rolle, Charlotte-Paige; Berhe, Mezgebe; Singh, Tulika; Ortiz, Roberto; Wurapa, Anson; Ramgopal, Moti; Leone, Peter A.; Matthews, Jessica E.; Dalessandro, Marybeth; Underwood, Mark R.; Angelis, Konstantinos; Wynne, Brian R.; Merrill, Deanna; Nguyen, Christopher; van Wyk, Jean; Zolopa, Andrew R. Journal: AIDS Issue: Volume 35:Number 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect on SARS-CoV-2 viral load using combination therapy with casirivimab/imdevimab and remdesivir. Issue 5 (15th September 2022) Authors: Kataria, Vivek K.; Berhe, Mezgebe; Sandkovsky, Uriel Journal: Proceedings Issue: Volume 35:Issue 5(2022) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗